These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11790390)

  • 1. Neuronal apoptosis induced by cerebrospinal fluid from multiple sclerosis patients correlates with hypointense lesions on T1 magnetic resonance imaging.
    Cid C; Alcázar A; Regidor I; Masjuan J; Salinas M; Alvarez-Cermeño JC
    J Neurol Sci; 2002 Jan; 193(2):103-9. PubMed ID: 11790390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspase inhibitors protect against neuronal apoptosis induced by cerebrospinal fluid from multiple sclerosis patients.
    Cid C; Alvarez-Cermeño JC; Regidor I; Plaza J; Salinas M; Alcázar A
    J Neuroimmunol; 2003 Mar; 136(1-2):119-24. PubMed ID: 12620650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal IgM index correlates with a severe disease course in multiple sclerosis: Clinical and MRI results.
    Ozakbas S; Cinar BP; Özcelik P; Baser H; Kosehasanoğullari G
    Clin Neurol Neurosurg; 2017 Sep; 160():27-29. PubMed ID: 28622533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infratentorial hypointense lesion volume on T1-weighted magnetic resonance imaging correlates with disability in patients with chronic cerebellar ataxia due to multiple sclerosis.
    Hickman SJ; Brierley CM; Silver NC; Moseley IF; Scolding NJ; Compston DA; Miller DH
    J Neurol Sci; 2001 Jun; 187(1-2):35-9. PubMed ID: 11440742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical Cord T1-weighted Hypointense Lesions at MR Imaging in Multiple Sclerosis: Relationship to Cord Atrophy and Disability.
    Valsasina P; Aboulwafa M; Preziosa P; Messina R; Falini A; Comi G; Filippi M; Rocca MA
    Radiology; 2018 Jul; 288(1):234-244. PubMed ID: 29664341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis.
    Rejdak K; Eikelenboom MJ; Petzold A; Thompson EJ; Stelmasiak Z; Lazeron RH; Barkhof F; Polman CH; Uitdehaag BM; Giovannoni G
    Neurology; 2004 Oct; 63(8):1439-45. PubMed ID: 15505162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volumes of brain atrophy and plaques correlated with neurological disability in secondary progressive multiple sclerosis.
    Dastidar P; Heinonen T; Lehtimäki T; Ukkonen M; Peltola J; Erilä T; Laasonen E; Elovaara I
    J Neurol Sci; 1999 May; 165(1):36-42. PubMed ID: 10426145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI detection of hypointense brain lesions in patients with multiple sclerosis: T1 spin-echo vs. gradient-echo.
    Dupuy SL; Tauhid S; Kim G; Chu R; Tummala S; Hurwitz S; Bakshi R
    Eur J Radiol; 2015 Aug; 84(8):1564-1568. PubMed ID: 26044294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal immunoglobulin G synthesis and brain injury by quantitative MRI in multiple sclerosis.
    Brandão CO; Ruocco HH; Farias AS; Oliveira C; Cendes F; Damasceno BP; Santos LM
    Neuroimmunomodulation; 2006; 13(2):89-95. PubMed ID: 17033198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis: relations between MRI and CT findings, cerebrospinal fluid parameters and clinical features.
    Baum K; Nehrig C; Girke W; Bräu H; Schörner W
    Clin Neurol Neurosurg; 1990; 92(1):49-56. PubMed ID: 2154355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis.
    Brettschneider J; Petzold A; Junker A; Tumani H
    Mult Scler; 2006 Apr; 12(2):143-8. PubMed ID: 16629417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and MRI correlates of CSF neurofilament light chain levels in relapsing and progressive MS.
    Damasceno A; Dias-Carneiro RPC; Moraes AS; Boldrini VO; Quintiliano RPS; da Silva VAPG; Farias AS; Brandão CO; Damasceno BP; Dos Santos LMB; Cendes F
    Mult Scler Relat Disord; 2019 May; 30():149-153. PubMed ID: 30772673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients.
    Thaler C; Faizy T; Sedlacik J; Holst B; Stellmann JP; Young KL; Heesen C; Fiehler J; Siemonsen S
    PLoS One; 2015; 10(12):e0144693. PubMed ID: 26659852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T1 hypointense lesion load in secondary progressive multiple sclerosis: a comparison of pre versus post contrast loads and of manual versus semi automated threshold techniques for lesion segmentation.
    O'Riordan JI; Gawne Cain M; Coles A; Wang L; Compston DA; Tofts P; Miller DH
    Mult Scler; 1998 Oct; 4(5):408-12. PubMed ID: 9839300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disability and lesion load in MS: a reassessment with MS functional composite score and 3D fast FLAIR.
    Ciccarelli O; Brex PA; Thompson AJ; Miller DH
    J Neurol; 2002 Jan; 249(1):18-24. PubMed ID: 11954864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axonal damage induced by cerebrospinal fluid from patients with relapsing-remitting multiple sclerosis.
    Alcázar A; Regidor I; Masjuan J; Salinas M; Alvarez-Cermeño JC
    J Neuroimmunol; 2000 Apr; 104(1):58-67. PubMed ID: 10683515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cerebrospinal fluid from patients with multiple sclerosis promotes neuronal and oligodendrocyte damage by delayed production of nitric oxide in vitro.
    Xiao BG; Zhang GX; Ma CG; Link H
    J Neurol Sci; 1996 Oct; 142(1-2):114-20. PubMed ID: 8902730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI measures and their relations with clinical disability in relapsing-remitting and secondary progressive multiple sclerosis.
    Giugni E; Pozzilli C; Bastianello S; Gasperini C; Paolillo A; Koudriavtseva T; Frontoni M; Farina D; Bozzao L
    Mult Scler; 1997 Aug; 3(4):221-5. PubMed ID: 9372503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.
    van Walderveen MA; Lycklama A Nijeholt GJ; Adèr HJ; Jongen PJ; Polman CH; Castelijns JA; Barkhof F
    Arch Neurol; 2001 Jan; 58(1):76-81. PubMed ID: 11176939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis.
    Vogt MH; Teunissen CE; Iacobaeus E; Heijnen DA; Breij EC; Olsson T; Brundin L; Killestein J; Dijkstra CD
    J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1110-5. PubMed ID: 18931010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.